Search

Roy Mohsen Helmy

from Sayreville, NJ
Age ~47
Get Report
Also known as:
Roy M Helmy, Roy N Helmy, Roy Helmy As, Roy Helan, Roy N Helny, Margarita Li
Phone and address:
2 Kania Ct, Sayreville, NJ 08872
(732) 887-2206
Related to:
Choy Y Li, 52Suzanne M Helmy, 39Kam W Li, 68Mohsen H Helmy, 76Li C Chen, 64Carmen Li, 36Victor Chiu Li, 64Maher H Helmy, 79Sau F Li, 72Rosa Chiu Li, 64Choyying J Li, 52Margarita Helmy, 52Diane E HelmyChoyying Li Ying, 52
Connected to:
Amir Helmy, 36Eric K Helmy, 50Essam M Helmy, 60Galal E Helmy, 97Gihan K Helmy, 61Hannah L Helmy, 42Lori A Helmy, 57Marie E Helmy, 32Mohamed O Helmy, 40Yara Helmy, 31

Roy Helmy Phones & Addresses

  • 2 Kania Ct, Sayreville, NJ 08872 (732) 887-2206
  • 451 64Th St, Brooklyn, NY 11220 (718) 492-1482
  • 7 Borelle Sq, Parlin, NJ 08859 (732) 721-0603
  • Old Bridge, NJ
  • New York, NY
  • Sergeantsville, NJ

Work

Company: Merck Jan 2016 to Jan 2018 Position: Director of analytical science , automation, and pharm degradation mechanism teams

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Seton Hall University 2000 to 2005 Specialities: Philosophy, Chemistry

Skills

Leadership • Pharmaceutical Industry • Research • Good Manufacturing Practice • Public Speaking • Innovation • Motivator

Industries

Pharmaceuticals

Resumes

Resumes

Roy Helmy Photo 1

Executive Director For Ppdm Bio-Analytical Vaccine And Biologics

View page
Location:
2 Kania Ct, Sayreville, NJ 08872
Industry:
Pharmaceuticals
Work:
Merck Jan 2016 - Jan 2018
Director of Analytical Science , Automation, and Pharm Degradation Mechanism Teams
Merck Jan 2016 - Jan 2018
Executive Director For Ppdm Bio-Analytical Vaccine and Biologics
Merck Jan 2014 - Jan 2016
Director of Analytical Enabling Technology Team, Merck Research Laboratories
Merck Jan 2012 - Jan 2014
Director of Chemistry , Merck Research Laboratories
Merck Jan 1998 - Jan 2012
Scientist To Research Fellow
Education:
Seton Hall University 2000 - 2005
Doctorates, Doctor of Philosophy, Philosophy, Chemistry Manhattan College 1995 - 1999
Bachelors, Bachelor of Science, Biochemistry
Skills:
Leadership
Pharmaceutical Industry
Research
Good Manufacturing Practice
Public Speaking
Innovation
Motivator

Publications

Us Patents

Substituted Furo[2,3-B] Pyridine Derivatives As Cannabinoid-1 Receptor Modulators

View page
US Patent:
20080269279, Oct 30, 2008
Filed:
Apr 7, 2008
Appl. No.:
12/082013
Inventors:
Matthew J. Clements - Old Bridge NJ, US
John S. Debenham - Scotch Plains NJ, US
Jeffrey J. Hale - Westfield NJ, US
Thomas F. Walsh - Watchung NJ, US
Andrey V. Peresypkin - Cambridge MA, US
Roy Helmy - Sayreville NJ, US
International Classification:
A61K 31/4355
C07D 471/04
A61P 25/00
A61P 3/04
US Classification:
514302, 546115, 546116
Abstract:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, Alzheimer's disease, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, cirrhosis of the liver, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and the promotion of wakefulness.

Methods For Analyzing Stability Of An Active Pharmaceutical Ingredient

View page
US Patent:
20190219555, Jul 18, 2019
Filed:
Jan 11, 2019
Appl. No.:
16/245703
Inventors:
- West Lafayette IN, US
Roy Helmy - Kenilworth NJ, US
Yangjie Li - West Layfayette IN, US
Yong Liu - Kenilworth NJ, US
International Classification:
G01N 33/15
H01J 49/00
H01J 49/04
Abstract:
The invention generally relates to methods for analyzing stability of an active pharmaceutical agent. In certain aspects, the methods involve obtaining an active pharmaceutical agent, and distributing the active pharmaceutical agent into one or more microdroplets. The one or more microdroplets including the active pharmaceutical agent are then subjected to one or more conditions that force degradation of the active pharmaceutical agent in each of the one or more microdroplets. The one or more microdroplets are then analyzed to determine a ratio of the active pharmaceutical agent to that of a degradation product of the active pharmaceutical agent, thereby analyzing stability of an active pharmaceutical agent.
Control profile
Roy Mohsen Helmy from Sayreville, NJ, age ~47 Get Report